DALLAS, May 01, 2018 -- Via OTC PR Wire – Puration, Inc. (USOTC:PURA) Today announced plans to produce a THC infused beverage in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer. The new THC infused beverage will expand Puration’s current cannabis infused beverage business. Last year, Puration introduced EVERx, a CBD infused sports water. The sales of EVERx yielded over a 60% gross margin as reported in the company’s 2017 annual report. The initial sales have won the interest of additional distributors to include a recently announced national distribution contract. Puration has designed a THC infused beverage and registered the name THCSavor. Package design is underway. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation scheduled for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350


Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market
Ireland’s Data Protection Commission Launches GDPR Investigation Into X’s AI Chatbot Grok
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings
BHP Group Half-Year Profit Surges as Copper Overtakes Iron Ore on AI-Driven Demand
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16%
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro
Reese’s Peanut Butter Cup Recipe Debate: Hershey Responds as Cocoa Prices Shift
YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails
Freedom Finance and Binance Join Forces in Digital Assets 



